Aytac Gulcu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aytac Gulcu has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alper Soylu
Department of Pediatric Nephrology Dokuz Eylül University Medical Faculty İzmir Turkey
2 shared publications - Aras Emre Canda
KRC Private Clinic for Colorectal Surgery and Peritoneal Carcinomatosis, Izmir, Turkey
1 shared publication Ayca Yigit
İzmir Biomedicine and Genome Center İzmir Türkiye
1 shared publication- Belde Kasap Demir
Department of Pediatric Rheumatology, Izmir Katip Celebi University, Izmir, Turkey
1 shared publication - Göksel Bengi
Department of Gastroenterology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye
1 shared publication - Hüseyin Döngelli
Department of Internal Medicine, Faculty of Medicine, Dokuz Eylül University, Izmir 35340, Turkey
1 shared publication
Latest Publications
- 5 April 2026
- Published by Wiley in American Journal of Medical Genetics Part A
Grange‐Like Phenotype Associated With an RNF213 Pathogenic Variant: Expanding the Vasculopathy Spectrum
Grange syndrome, caused by biallelic loss‐of‐function variants in YY1AP1 , is characterized by multivascular stenoses, renovascular hypertension, brachydactyly, syndactyly, and mild cognitive impairment. Although RNF213 variants are typically associated with Moyamoya disease and systemic arterial stenosis, evidence suggests that pathogenic RNF213 variants may contribute to a broader vascular phenotype. We describe a 15‐year‐old girl with Moyamoya vasculopathy presenting with bilateral renal artery stenosis, brachydactyly, and intellectual disability. Her history included left‐arm weakness and seizures at 10 months of age. She underwent surgical revascularization at 1.5 and 3 years of age for Moyamoya disease. Upon evaluation for hypertension, the patient was diagnosed with bilateral renal artery stenosis. Physical examination revealed dysmorphic features including deep‐set eyes, up slanting palpebral fissures, a broad nasal bridge, low‐set, posteriorly rotated ears, a broad left thumb, brachydactyly, and syndactyly of the toes. Whole‐exome sequencing was negative; trio whole‐genome sequencing identified a de novo, likely pathogenic RNF213 variant (c.12341C > G). This case expands the phenotypic spectrum associated with RNF213 variants, presenting a Grange‐like phenotype. Our study highlights RNF213 as a candidate gene for such phenotypes. A negative YY1AP1 result does not exclude a Grange‐like phenotype, emphasizing the need for comprehensive genetic testing and early vascular surveillance.
- 5 April 2026
- Published by Wiley in American Journal of Medical Genetics Part A
Grange‐Like Phenotype Associated With an RNF213 Pathogenic Variant: Expanding the Vasculopathy Spectrum
Grange syndrome, caused by biallelic loss‐of‐function variants in YY1AP1 , is characterized by multivascular stenoses, renovascular hypertension, brachydactyly, syndactyly, and mild cognitive impairment. Although RNF213 variants are typically associated with Moyamoya disease and systemic arterial stenosis, evidence suggests that pathogenic RNF213 variants may contribute to a broader vascular phenotype. We describe a 15‐year‐old girl with Moyamoya vasculopathy presenting with bilateral renal artery stenosis, brachydactyly, and intellectual disability. Her history included left‐arm weakness and seizures at 10 months of age. She underwent surgical revascularization at 1.5 and 3 years of age for Moyamoya disease. Upon evaluation for hypertension, the patient was diagnosed with bilateral renal artery stenosis. Physical examination revealed dysmorphic features including deep‐set eyes, up slanting palpebral fissures, a broad nasal bridge, low‐set, posteriorly rotated ears, a broad left thumb, brachydactyly, and syndactyly of the toes. Whole‐exome sequencing was negative; trio whole‐genome sequencing identified a de novo, likely pathogenic RNF213 variant (c.12341C > G). This case expands the phenotypic spectrum associated with RNF213 variants, presenting a Grange‐like phenotype. Our study highlights RNF213 as a candidate gene for such phenotypes. A negative YY1AP1 result does not exclude a Grange‐like phenotype, emphasizing the need for comprehensive genetic testing and early vascular surveillance.
- Open Access
- 29 March 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (4)
Massive Recurrent Bleeding From Parastomal Caput Medusae
Ectopic variceal bleeding is a rare but life‐threatening complication of portal hypertension. For severe parastomal variceal hemorrhage unresponsive to conservative therapy, endovascular embolization is a safe, minimally invasive, repeatable, and effective life‐saving alternative, particularly in patients with portal hypertension and hepatic dysfunction.
- 29 March 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (4)
Open AccessMassive Recurrent Bleeding From Parastomal Caput Medusae
Ectopic variceal bleeding is a rare but life‐threatening complication of portal hypertension. For severe parastomal variceal hemorrhage unresponsive to conservative therapy, endovascular embolization is a safe, minimally invasive, repeatable, and effective life‐saving alternative, particularly in patients with portal hypertension and hepatic dysfunction.
- Open Access
- 31 January 2025
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 9 (1) , 182-187
Peripheral Blood Cell Changes And Outcomes After Partial Splenic Embolization For Hypersplenism İn Cirrhotic Patients
Background and Purpose: Partial splenic embolization is a common treatment for hypersplenism in patients with cirrhosis. In this investigation, we evaluated the effectiveness and safety of partial splenic embolization in patients with cirrhosis. Methods: We retrospectively investigated 17 patients with hypersplenism secondary to cirrhosis who underwent partial splenic embolization. Following partial splenic embolization, peripheral blood cell counts were measured at regular intervals over a period of twelve months.Post-procedural complications were recorded. Results: This study included 17 individuals, with a mean age of 54.5 ± 10 years. Hemoglobin, platelet, neutrophil, lymphocyte, and white blood cell counts showed statistically significant increases.when compared to the pre-procedure levels at each time point (pre-procedure vs. 1st day p
- 31 January 2025
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 9 (1) , 182-187
Open AccessPeripheral Blood Cell Changes And Outcomes After Partial Splenic Embolization For Hypersplenism İn Cirrhotic Patients
Background and Purpose: Partial splenic embolization is a common treatment for hypersplenism in patients with cirrhosis. In this investigation, we evaluated the effectiveness and safety of partial splenic embolization in patients with cirrhosis. Methods: We retrospectively investigated 17 patients with hypersplenism secondary to cirrhosis who underwent partial splenic embolization. Following partial splenic embolization, peripheral blood cell counts were measured at regular intervals over a period of twelve months.Post-procedural complications were recorded. Results: This study included 17 individuals, with a mean age of 54.5 ± 10 years. Hemoglobin, platelet, neutrophil, lymphocyte, and white blood cell counts showed statistically significant increases.when compared to the pre-procedure levels at each time point (pre-procedure vs. 1st day p
- 23 December 2021
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 61 (6) , e148-e150
Recurrent perirenal hematomas and brachial plexopathy in a boy with familial Mediterranean fever associated polyarteritis nodosa
- 23 December 2021
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 61 (6) , e148-e150
Recurrent perirenal hematomas and brachial plexopathy in a boy with familial Mediterranean fever associated polyarteritis nodosa